Southampton's University Hospital manages HIV and Hepatitis B patients across Hampshire and the Isle of Wight. Southampton's port city character — historically attracting merchant seafarers, international workers, and a significant student population from University of Southampton — creates a mobile population with diverse healthcare needs including antiviral access. Tavin TDF 300mg provides affordable dual-indication therapy for both HIV and Hepatitis B at significantly reduced cost.
Southampton's large Chinese student community from University of Southampton — from a country with endemic Hepatitis B — creates specific demand for affordable, long-term HBV management. Tavin's WHO-GMP certification gives Southampton physicians confidence in its clinical equivalence to brand Viread.
Visit medshopy.com or WhatsApp +91 82650 41513.
Southampton's large Chinese student community from University of Southampton — from a country with endemic Hepatitis B — creates specific demand for affordable, long-term HBV management. Tavin's WHO-GMP certification gives Southampton physicians confidence in its clinical equivalence to brand Viread.
Visit medshopy.com or WhatsApp +91 82650 41513.
Should I take Hepatitis B vaccination even if I'm already taking Tavin for HIV — am I already protected?This depends on your HBV status. TDF (Tavin) has activity against Hepatitis B virus, but it's a treatment for existing infection — not a vaccine providing immunity. If you are HIV-positive and HBV-negative (no active infection and no immunity), you should absolutely receive the Hepatitis B vaccine series, as it will provide protective immunity against future HBV exposure. The vaccine works just as well in HIV-positive individuals on stable, well-suppressed antiretroviral therapy, though response rates may be somewhat lower than in immunocompetent individuals. Your Southampton HIV clinic will routinely check Hepatitis B vaccination status and offer vaccination to all HBV-naïve HIV-positive patients as part of standard HIV care.
